Rigele Abilock

Keine laufenden Positionen mehr

54 Jahre

Health Technology

Finance

Profil

Rigele Abilock joined SLS Venture in 2004, having previously worked with H.
Lundbeck A/S (Copenhagen) in Corporate Business Development.
From 1998-2003, Ms. Abilock was at Maxygen, Inc. in Redwood City, California, where she headed therapeutics business development across both the California and Copenhagen sites, and served on the global therapeutics management team.
She also had a substantial role in financing activities, including the company's Nasdaq IPO in 1999.
Rigele Abilock holds an MBA from the Massachusetts Institute of Technology (M.I.T.).
Her undergraduate studies are in English and Molecular Biology from Pomona College, California.

Ehemalige bekannte Positionen von Rigele Abilock

Unternehmen	Position	Ende
Scandinavian Life Science Invest ApS Scandinavian Life Science Invest ApS Investment ManagersFinance Scandinavian Life Science Invest ApS (Scandinavian Life Science Invest) is a venture capital firm with offices in Copenhagen and Stockholm. They were founded in 2000. Scandinavian Life Science Invest was created following the merger of the life science team from The Sixth Swedish National Pension Fund, Medicon Valley Capital and Innoventus. Their investor base comprises Scandinavian pension funds, financial institutions, life science firms, and banks.	Director of Investments	31.12.2010
Biolipox AB Biolipox AB Pharmaceuticals: MajorHealth Technology Biolipox AB develops and manufactures pharmaceuticals products. The company engages in the research and development of pharmaceuticals for the treatment of respiratory and other inflammatory diseases such as asthma, chronic obstructive pulmonary disease, rhinitis, pain, and arthritis. It was founded in June 2000 and is headquartered in Solna, Sweden.	Direktor/Vorstandsmitglied	-

Sehen Sie sich die Erfahrung von Rigele Abilock im Detail an

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen